Medtronic has announced the launch of the Avalus Ultra valve, an advanced surgical aortic tissue valve. The valve is engineered to simplify the implantation process and facilitate lifetime patient ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest version of its transcatheter aortic valve replacement implant.

Transscatheter aortic valve replacement is a novel way to replace ... but not yet approved by the FDA, is the Medtronic CoreValve. It also has gone through three generations of design improvements.

This is because space is required to accommodate the excluded native aortic valve leaflets, which otherwise could compromise coronary arterial flow. Since the Medtronic CoreValve device is a much ...

The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...

Medtronic offers both aortic root cannulae and coronary ostial cannulae. Aortic root cannulae are intended to infuse cardioplegia directly into the aortic root near the aortic valve while coronary ...

A randomized trial of patients with a narrowing of their heart’s aortic valve, but who had not yet begun to show the symptoms ...

Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to ...

Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

In older people with asymptomatic severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF), ...

The result calls into question the prospects of FDA approval for the Acurate neo2 valve, which is already in use globally.